A 14 day esomeprazole- and amoxicillin-containing high-dose dual therapy regimen achieves a high eradication rate as first-line anti-Helicobacter pylori treatment in Taiwan: a prospective randomized trial-Reference-Cited by-同舟云学术

A 14 day esomeprazole- and amoxicillin-containing high-dose dual therapy regimen achieves a high eradication rate as first-line anti-Helicobacter pylori treatment in Taiwan: a prospective randomized trial

Published:2019-02-14 Issue:6 Volume:74 Page:1718-1724
ISSN:0305-7453
Container-title:Journal of Antimicrobial Chemotherapy
language:en
Short-container-title:

Author:

Tai Wei-Chen¹²,Liang Chih-Ming¹,Kuo Chung-Mou¹,Huang Pao-Yuan¹,Wu Cheng-Kun¹,Yang Shih-Cheng¹,Kuo Yuan-Hung¹²,Lin Ming-Tsung¹²,Lee Chen-Hsiang²³,Hsu Chien-Ning⁴⁵,Wu Keng-Liang¹²,Hu Tsung-Hui¹²^ORCID,Chuah Seng-Kee¹²^ORCID

Affiliation:

1. Division of Hepatogastroenterology, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan

2. Chang Gung University College of Medicine, Kaohsiung, Taiwan

3. Division of Infectious Diseases, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan

4. Department of Pharmacy, Kaohsiung Gang Gung Memorial Hospital, Kaohsiung, Taiwan

5. School of Pharmacy, Kaohsiung Medical University, Kaohsiung, Taiwan

Funder

Research Foundation of Chang Gung Memorial Hospital

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology,Microbiology (medical)

Link

http://academic.oup.com/jac/article-pdf/74/6/1718/28666523/dkz046.pdf

Reference37 articles.

1. Optimal therapy for Helicobacter pylori infections;Rimbara;Nat Rev Gastroenterol Hepatol,2011

2. Second Asia-Pacific conference. Second Asia-Pacific Consensus guidelines for Helicobacter pylori infection;Fock;J Gastroenterol Hepatol,2009

3. Helicobacter pylori treatment in the era of increasing antibiotic resistance;Graham;Gut,2010

4. Evolution of Helicobacter pylori therapy from a metaanalytical perspective;Gisbert;Helicobacter,2007

5. Seven-day non-bismuth containing quadruple therapy could achieve a grade ‘A’ success rate for first-line Helicobacter pylori eradication;Tai;Biomed Res Int,2015

Cited by 72 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The multicenter real-world report of the efficacies of 14-day esomeprazole-based and rabeprazole-based high-dose dual therapy in first-line Helicobacter pylori eradication in Taiwan;Journal of Microbiology, Immunology and Infection;2024-08

2. Impact of medication dosage on Helicobacter pylori eradication rates among pediatric patients;Journal of Pediatric Gastroenterology and Nutrition;2024-05-08

3. High‐dose dual therapy versus bismuth‐containing quadruple therapy for the eradication of Helicobacter pylori: A systematic review and meta‐analysis;Journal of Digestive Diseases;2024-03

4. Crises in Antimicrobial Stewardship: Misuse of Clarithromycin for Helicobacter pylori Therapy;Pharmacoepidemiology;2024-02-20

5. Managing Helicobacter pylori infection: transitioning from conventional to alternative treatment approaches;The European Research Journal;2024-01-04